nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—colon cancer—Betamethasone—psoriatic arthritis	0.282	0.366	CpDpCtD
Aprepitant—colon cancer—Dexamethasone—psoriatic arthritis	0.282	0.366	CpDpCtD
Aprepitant—breast cancer—Dexamethasone—psoriatic arthritis	0.104	0.134	CpDpCtD
Aprepitant—breast cancer—Betamethasone—psoriatic arthritis	0.104	0.134	CpDpCtD
Aprepitant—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.0187	0.126	CbGbCtD
Aprepitant—CYP3A7—Dexamethasone—psoriatic arthritis	0.0187	0.126	CbGbCtD
Aprepitant—CYP2C19—Prednisone—psoriatic arthritis	0.0181	0.122	CbGbCtD
Aprepitant—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0145	0.0973	CbGbCtD
Aprepitant—CYP3A5—Dexamethasone—psoriatic arthritis	0.014	0.0944	CbGbCtD
Aprepitant—CYP2C19—Dexamethasone—psoriatic arthritis	0.0113	0.0761	CbGbCtD
Aprepitant—CYP3A4—Triamcinolone—psoriatic arthritis	0.011	0.0738	CbGbCtD
Aprepitant—CYP2C9—Dexamethasone—psoriatic arthritis	0.00941	0.0633	CbGbCtD
Aprepitant—CYP3A4—Betamethasone—psoriatic arthritis	0.00941	0.0633	CbGbCtD
Aprepitant—CYP3A4—Prednisolone—psoriatic arthritis	0.00928	0.0624	CbGbCtD
Aprepitant—CYP3A4—Prednisone—psoriatic arthritis	0.00876	0.059	CbGbCtD
Aprepitant—CYP3A4—Dexamethasone—psoriatic arthritis	0.00547	0.0368	CbGbCtD
Aprepitant—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000105	0.00131	CcSEcCtD
Aprepitant—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000105	0.00131	CcSEcCtD
Aprepitant—Syncope—Betamethasone—psoriatic arthritis	0.000104	0.00131	CcSEcCtD
Aprepitant—Syncope—Dexamethasone—psoriatic arthritis	0.000104	0.00131	CcSEcCtD
Aprepitant—Infection—Triamcinolone—psoriatic arthritis	0.000104	0.0013	CcSEcCtD
Aprepitant—Infection—Methylprednisolone—psoriatic arthritis	0.000104	0.0013	CcSEcCtD
Aprepitant—Haematuria—Methotrexate—psoriatic arthritis	0.000103	0.00129	CcSEcCtD
Aprepitant—Shock—Triamcinolone—psoriatic arthritis	0.000103	0.00129	CcSEcCtD
Aprepitant—Insomnia—Prednisolone—psoriatic arthritis	0.000103	0.00129	CcSEcCtD
Aprepitant—Alopecia—Prednisone—psoriatic arthritis	0.000103	0.00129	CcSEcCtD
Aprepitant—Shock—Methylprednisolone—psoriatic arthritis	0.000103	0.00129	CcSEcCtD
Aprepitant—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000103	0.00128	CcSEcCtD
Aprepitant—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Paraesthesia—Prednisolone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Tachycardia—Triamcinolone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Mental disorder—Prednisone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000102	0.00128	CcSEcCtD
Aprepitant—Skin disorder—Methylprednisolone—psoriatic arthritis	0.000102	0.00127	CcSEcCtD
Aprepitant—Malnutrition—Prednisone—psoriatic arthritis	0.000101	0.00127	CcSEcCtD
Aprepitant—Erythema—Prednisone—psoriatic arthritis	0.000101	0.00127	CcSEcCtD
Aprepitant—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000101	0.00127	CcSEcCtD
Aprepitant—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000101	0.00126	CcSEcCtD
Aprepitant—Convulsion—Dexamethasone—psoriatic arthritis	0.000101	0.00126	CcSEcCtD
Aprepitant—Convulsion—Betamethasone—psoriatic arthritis	0.000101	0.00126	CcSEcCtD
Aprepitant—Hypertension—Dexamethasone—psoriatic arthritis	0.000101	0.00126	CcSEcCtD
Aprepitant—Hypertension—Betamethasone—psoriatic arthritis	0.000101	0.00126	CcSEcCtD
Aprepitant—Myalgia—Dexamethasone—psoriatic arthritis	9.92e-05	0.00124	CcSEcCtD
Aprepitant—Myalgia—Betamethasone—psoriatic arthritis	9.92e-05	0.00124	CcSEcCtD
Aprepitant—Anxiety—Dexamethasone—psoriatic arthritis	9.88e-05	0.00124	CcSEcCtD
Aprepitant—Anxiety—Betamethasone—psoriatic arthritis	9.88e-05	0.00124	CcSEcCtD
Aprepitant—Discomfort—Dexamethasone—psoriatic arthritis	9.8e-05	0.00122	CcSEcCtD
Aprepitant—Discomfort—Betamethasone—psoriatic arthritis	9.8e-05	0.00122	CcSEcCtD
Aprepitant—Hypotension—Methylprednisolone—psoriatic arthritis	9.77e-05	0.00122	CcSEcCtD
Aprepitant—Pain—Prednisolone—psoriatic arthritis	9.74e-05	0.00122	CcSEcCtD
Aprepitant—Pharyngitis—Methotrexate—psoriatic arthritis	9.67e-05	0.00121	CcSEcCtD
Aprepitant—Urinary tract disorder—Methotrexate—psoriatic arthritis	9.62e-05	0.0012	CcSEcCtD
Aprepitant—Urethral disorder—Methotrexate—psoriatic arthritis	9.55e-05	0.00119	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	9.55e-05	0.00119	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	9.53e-05	0.00119	CcSEcCtD
Aprepitant—Anaphylactic shock—Dexamethasone—psoriatic arthritis	9.51e-05	0.00119	CcSEcCtD
Aprepitant—Oedema—Betamethasone—psoriatic arthritis	9.51e-05	0.00119	CcSEcCtD
Aprepitant—Oedema—Dexamethasone—psoriatic arthritis	9.51e-05	0.00119	CcSEcCtD
Aprepitant—Anaphylactic shock—Betamethasone—psoriatic arthritis	9.51e-05	0.00119	CcSEcCtD
Aprepitant—Insomnia—Triamcinolone—psoriatic arthritis	9.48e-05	0.00118	CcSEcCtD
Aprepitant—Insomnia—Methylprednisolone—psoriatic arthritis	9.46e-05	0.00118	CcSEcCtD
Aprepitant—Infection—Betamethasone—psoriatic arthritis	9.45e-05	0.00118	CcSEcCtD
Aprepitant—Infection—Dexamethasone—psoriatic arthritis	9.45e-05	0.00118	CcSEcCtD
Aprepitant—Ill-defined disorder—Prednisone—psoriatic arthritis	9.41e-05	0.00118	CcSEcCtD
Aprepitant—Paraesthesia—Triamcinolone—psoriatic arthritis	9.41e-05	0.00118	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisolone—psoriatic arthritis	9.39e-05	0.00117	CcSEcCtD
Aprepitant—Paraesthesia—Methylprednisolone—psoriatic arthritis	9.39e-05	0.00117	CcSEcCtD
Aprepitant—Anaemia—Prednisone—psoriatic arthritis	9.38e-05	0.00117	CcSEcCtD
Aprepitant—Shock—Dexamethasone—psoriatic arthritis	9.35e-05	0.00117	CcSEcCtD
Aprepitant—Shock—Betamethasone—psoriatic arthritis	9.35e-05	0.00117	CcSEcCtD
Aprepitant—Dyspnoea—Triamcinolone—psoriatic arthritis	9.34e-05	0.00117	CcSEcCtD
Aprepitant—Nervous system disorder—Betamethasone—psoriatic arthritis	9.32e-05	0.00117	CcSEcCtD
Aprepitant—Nervous system disorder—Dexamethasone—psoriatic arthritis	9.32e-05	0.00117	CcSEcCtD
Aprepitant—Thrombocytopenia—Betamethasone—psoriatic arthritis	9.31e-05	0.00116	CcSEcCtD
Aprepitant—Thrombocytopenia—Dexamethasone—psoriatic arthritis	9.31e-05	0.00116	CcSEcCtD
Aprepitant—Tachycardia—Betamethasone—psoriatic arthritis	9.28e-05	0.00116	CcSEcCtD
Aprepitant—Tachycardia—Dexamethasone—psoriatic arthritis	9.28e-05	0.00116	CcSEcCtD
Aprepitant—Angioedema—Prednisone—psoriatic arthritis	9.27e-05	0.00116	CcSEcCtD
Aprepitant—Dyspepsia—Triamcinolone—psoriatic arthritis	9.22e-05	0.00115	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—psoriatic arthritis	9.21e-05	0.00115	CcSEcCtD
Aprepitant—Dyspepsia—Methylprednisolone—psoriatic arthritis	9.2e-05	0.00115	CcSEcCtD
Aprepitant—Hyperhidrosis—Dexamethasone—psoriatic arthritis	9.19e-05	0.00115	CcSEcCtD
Aprepitant—Hyperhidrosis—Betamethasone—psoriatic arthritis	9.19e-05	0.00115	CcSEcCtD
Aprepitant—Malaise—Prednisone—psoriatic arthritis	9.15e-05	0.00114	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—psoriatic arthritis	9.1e-05	0.00114	CcSEcCtD
Aprepitant—Syncope—Prednisone—psoriatic arthritis	9.1e-05	0.00114	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—psoriatic arthritis	9.08e-05	0.00114	CcSEcCtD
Aprepitant—Anorexia—Betamethasone—psoriatic arthritis	9.06e-05	0.00113	CcSEcCtD
Aprepitant—Anorexia—Dexamethasone—psoriatic arthritis	9.06e-05	0.00113	CcSEcCtD
Aprepitant—Urticaria—Prednisolone—psoriatic arthritis	9.05e-05	0.00113	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—psoriatic arthritis	9.04e-05	0.00113	CcSEcCtD
Aprepitant—Fatigue—Triamcinolone—psoriatic arthritis	9.03e-05	0.00113	CcSEcCtD
Aprepitant—Fatigue—Methylprednisolone—psoriatic arthritis	9.01e-05	0.00113	CcSEcCtD
Aprepitant—Pain—Triamcinolone—psoriatic arthritis	8.96e-05	0.00112	CcSEcCtD
Aprepitant—Loss of consciousness—Prednisone—psoriatic arthritis	8.92e-05	0.00111	CcSEcCtD
Aprepitant—Hypotension—Dexamethasone—psoriatic arthritis	8.88e-05	0.00111	CcSEcCtD
Aprepitant—Hypotension—Betamethasone—psoriatic arthritis	8.88e-05	0.00111	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—psoriatic arthritis	8.84e-05	0.0011	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—psoriatic arthritis	8.8e-05	0.0011	CcSEcCtD
Aprepitant—Convulsion—Prednisone—psoriatic arthritis	8.79e-05	0.0011	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—psoriatic arthritis	8.78e-05	0.0011	CcSEcCtD
Aprepitant—Hypertension—Prednisone—psoriatic arthritis	8.76e-05	0.00109	CcSEcCtD
Aprepitant—Chills—Methotrexate—psoriatic arthritis	8.74e-05	0.00109	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	8.66e-05	0.00108	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	8.66e-05	0.00108	CcSEcCtD
Aprepitant—Myalgia—Prednisone—psoriatic arthritis	8.64e-05	0.00108	CcSEcCtD
Aprepitant—Arthralgia—Prednisone—psoriatic arthritis	8.64e-05	0.00108	CcSEcCtD
Aprepitant—Feeling abnormal—Triamcinolone—psoriatic arthritis	8.64e-05	0.00108	CcSEcCtD
Aprepitant—Feeling abnormal—Methylprednisolone—psoriatic arthritis	8.62e-05	0.00108	CcSEcCtD
Aprepitant—Anxiety—Prednisone—psoriatic arthritis	8.61e-05	0.00108	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—psoriatic arthritis	8.61e-05	0.00108	CcSEcCtD
Aprepitant—Insomnia—Dexamethasone—psoriatic arthritis	8.6e-05	0.00107	CcSEcCtD
Aprepitant—Insomnia—Betamethasone—psoriatic arthritis	8.6e-05	0.00107	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	8.58e-05	0.00107	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	8.55e-05	0.00107	CcSEcCtD
Aprepitant—Paraesthesia—Dexamethasone—psoriatic arthritis	8.54e-05	0.00107	CcSEcCtD
Aprepitant—Paraesthesia—Betamethasone—psoriatic arthritis	8.54e-05	0.00107	CcSEcCtD
Aprepitant—Discomfort—Prednisone—psoriatic arthritis	8.53e-05	0.00107	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—psoriatic arthritis	8.53e-05	0.00107	CcSEcCtD
Aprepitant—Erythema—Methotrexate—psoriatic arthritis	8.48e-05	0.00106	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—psoriatic arthritis	8.48e-05	0.00106	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisolone—psoriatic arthritis	8.4e-05	0.00105	CcSEcCtD
Aprepitant—Dyspepsia—Dexamethasone—psoriatic arthritis	8.37e-05	0.00105	CcSEcCtD
Aprepitant—Dyspepsia—Betamethasone—psoriatic arthritis	8.37e-05	0.00105	CcSEcCtD
Aprepitant—Urticaria—Triamcinolone—psoriatic arthritis	8.32e-05	0.00104	CcSEcCtD
Aprepitant—Urticaria—Methylprednisolone—psoriatic arthritis	8.31e-05	0.00104	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—psoriatic arthritis	8.3e-05	0.00104	CcSEcCtD
Aprepitant—Body temperature increased—Triamcinolone—psoriatic arthritis	8.28e-05	0.00104	CcSEcCtD
Aprepitant—Oedema—Prednisone—psoriatic arthritis	8.28e-05	0.00103	CcSEcCtD
Aprepitant—Anaphylactic shock—Prednisone—psoriatic arthritis	8.28e-05	0.00103	CcSEcCtD
Aprepitant—Abdominal pain—Methylprednisolone—psoriatic arthritis	8.27e-05	0.00103	CcSEcCtD
Aprepitant—Decreased appetite—Dexamethasone—psoriatic arthritis	8.27e-05	0.00103	CcSEcCtD
Aprepitant—Decreased appetite—Betamethasone—psoriatic arthritis	8.27e-05	0.00103	CcSEcCtD
Aprepitant—Infection—Prednisone—psoriatic arthritis	8.23e-05	0.00103	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	8.21e-05	0.00103	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	8.21e-05	0.00103	CcSEcCtD
Aprepitant—Back pain—Methotrexate—psoriatic arthritis	8.2e-05	0.00103	CcSEcCtD
Aprepitant—Fatigue—Betamethasone—psoriatic arthritis	8.2e-05	0.00102	CcSEcCtD
Aprepitant—Fatigue—Dexamethasone—psoriatic arthritis	8.2e-05	0.00102	CcSEcCtD
Aprepitant—Shock—Prednisone—psoriatic arthritis	8.15e-05	0.00102	CcSEcCtD
Aprepitant—Pain—Betamethasone—psoriatic arthritis	8.13e-05	0.00102	CcSEcCtD
Aprepitant—Pain—Dexamethasone—psoriatic arthritis	8.13e-05	0.00102	CcSEcCtD
Aprepitant—Nervous system disorder—Prednisone—psoriatic arthritis	8.12e-05	0.00101	CcSEcCtD
Aprepitant—Tachycardia—Prednisone—psoriatic arthritis	8.08e-05	0.00101	CcSEcCtD
Aprepitant—Skin disorder—Prednisone—psoriatic arthritis	8.04e-05	0.00101	CcSEcCtD
Aprepitant—Hyperhidrosis—Prednisone—psoriatic arthritis	8e-05	0.001	CcSEcCtD
Aprepitant—Anorexia—Prednisone—psoriatic arthritis	7.89e-05	0.000987	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—psoriatic arthritis	7.87e-05	0.000983	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—psoriatic arthritis	7.84e-05	0.00098	CcSEcCtD
Aprepitant—Feeling abnormal—Dexamethasone—psoriatic arthritis	7.84e-05	0.000979	CcSEcCtD
Aprepitant—Feeling abnormal—Betamethasone—psoriatic arthritis	7.84e-05	0.000979	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	7.78e-05	0.000972	CcSEcCtD
Aprepitant—Gastrointestinal pain—Betamethasone—psoriatic arthritis	7.78e-05	0.000972	CcSEcCtD
Aprepitant—Hypersensitivity—Triamcinolone—psoriatic arthritis	7.72e-05	0.000965	CcSEcCtD
Aprepitant—Hypersensitivity—Methylprednisolone—psoriatic arthritis	7.7e-05	0.000963	CcSEcCtD
Aprepitant—Malaise—Methotrexate—psoriatic arthritis	7.65e-05	0.000956	CcSEcCtD
Aprepitant—Urticaria—Betamethasone—psoriatic arthritis	7.55e-05	0.000944	CcSEcCtD
Aprepitant—Urticaria—Dexamethasone—psoriatic arthritis	7.55e-05	0.000944	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	7.54e-05	0.000943	CcSEcCtD
Aprepitant—Dizziness—Prednisolone—psoriatic arthritis	7.54e-05	0.000942	CcSEcCtD
Aprepitant—Asthenia—Triamcinolone—psoriatic arthritis	7.52e-05	0.00094	CcSEcCtD
Aprepitant—Abdominal pain—Dexamethasone—psoriatic arthritis	7.52e-05	0.000939	CcSEcCtD
Aprepitant—Body temperature increased—Betamethasone—psoriatic arthritis	7.52e-05	0.000939	CcSEcCtD
Aprepitant—Body temperature increased—Dexamethasone—psoriatic arthritis	7.52e-05	0.000939	CcSEcCtD
Aprepitant—Abdominal pain—Betamethasone—psoriatic arthritis	7.52e-05	0.000939	CcSEcCtD
Aprepitant—Asthenia—Methylprednisolone—psoriatic arthritis	7.5e-05	0.000938	CcSEcCtD
Aprepitant—Insomnia—Prednisone—psoriatic arthritis	7.49e-05	0.000936	CcSEcCtD
Aprepitant—Paraesthesia—Prednisone—psoriatic arthritis	7.44e-05	0.000929	CcSEcCtD
Aprepitant—Pruritus—Triamcinolone—psoriatic arthritis	7.41e-05	0.000927	CcSEcCtD
Aprepitant—Cough—Methotrexate—psoriatic arthritis	7.4e-05	0.000925	CcSEcCtD
Aprepitant—Pruritus—Methylprednisolone—psoriatic arthritis	7.4e-05	0.000925	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—psoriatic arthritis	7.35e-05	0.000918	CcSEcCtD
Aprepitant—Dyspepsia—Prednisone—psoriatic arthritis	7.29e-05	0.000911	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—psoriatic arthritis	7.22e-05	0.000902	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—psoriatic arthritis	7.22e-05	0.000902	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—psoriatic arthritis	7.22e-05	0.000902	CcSEcCtD
Aprepitant—Decreased appetite—Prednisone—psoriatic arthritis	7.2e-05	0.0009	CcSEcCtD
Aprepitant—Rash—Prednisolone—psoriatic arthritis	7.18e-05	0.000898	CcSEcCtD
Aprepitant—Dermatitis—Prednisolone—psoriatic arthritis	7.18e-05	0.000897	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	7.17e-05	0.000896	CcSEcCtD
Aprepitant—Diarrhoea—Methylprednisolone—psoriatic arthritis	7.15e-05	0.000894	CcSEcCtD
Aprepitant—Fatigue—Prednisone—psoriatic arthritis	7.14e-05	0.000892	CcSEcCtD
Aprepitant—Headache—Prednisolone—psoriatic arthritis	7.14e-05	0.000892	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—psoriatic arthritis	7.13e-05	0.000891	CcSEcCtD
Aprepitant—Constipation—Prednisone—psoriatic arthritis	7.08e-05	0.000885	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—psoriatic arthritis	6.98e-05	0.000872	CcSEcCtD
Aprepitant—Dizziness—Triamcinolone—psoriatic arthritis	6.93e-05	0.000866	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—psoriatic arthritis	6.92e-05	0.000865	CcSEcCtD
Aprepitant—Dizziness—Methylprednisolone—psoriatic arthritis	6.91e-05	0.000864	CcSEcCtD
Aprepitant—Infection—Methotrexate—psoriatic arthritis	6.88e-05	0.000859	CcSEcCtD
Aprepitant—Feeling abnormal—Prednisone—psoriatic arthritis	6.82e-05	0.000853	CcSEcCtD
Aprepitant—Asthenia—Dexamethasone—psoriatic arthritis	6.82e-05	0.000853	CcSEcCtD
Aprepitant—Asthenia—Betamethasone—psoriatic arthritis	6.82e-05	0.000853	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—psoriatic arthritis	6.79e-05	0.000848	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—psoriatic arthritis	6.78e-05	0.000847	CcSEcCtD
Aprepitant—Gastrointestinal pain—Prednisone—psoriatic arthritis	6.77e-05	0.000846	CcSEcCtD
Aprepitant—Nausea—Prednisolone—psoriatic arthritis	6.77e-05	0.000846	CcSEcCtD
Aprepitant—Pruritus—Betamethasone—psoriatic arthritis	6.73e-05	0.000841	CcSEcCtD
Aprepitant—Pruritus—Dexamethasone—psoriatic arthritis	6.73e-05	0.000841	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—psoriatic arthritis	6.72e-05	0.00084	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—psoriatic arthritis	6.69e-05	0.000836	CcSEcCtD
Aprepitant—Vomiting—Triamcinolone—psoriatic arthritis	6.66e-05	0.000833	CcSEcCtD
Aprepitant—Vomiting—Methylprednisolone—psoriatic arthritis	6.65e-05	0.000831	CcSEcCtD
Aprepitant—Rash—Triamcinolone—psoriatic arthritis	6.61e-05	0.000826	CcSEcCtD
Aprepitant—Dermatitis—Triamcinolone—psoriatic arthritis	6.6e-05	0.000825	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—psoriatic arthritis	6.6e-05	0.000824	CcSEcCtD
Aprepitant—Rash—Methylprednisolone—psoriatic arthritis	6.59e-05	0.000824	CcSEcCtD
Aprepitant—Dermatitis—Methylprednisolone—psoriatic arthritis	6.59e-05	0.000823	CcSEcCtD
Aprepitant—Urticaria—Prednisone—psoriatic arthritis	6.58e-05	0.000822	CcSEcCtD
Aprepitant—Headache—Triamcinolone—psoriatic arthritis	6.56e-05	0.000821	CcSEcCtD
Aprepitant—Headache—Methylprednisolone—psoriatic arthritis	6.55e-05	0.000819	CcSEcCtD
Aprepitant—Body temperature increased—Prednisone—psoriatic arthritis	6.55e-05	0.000818	CcSEcCtD
Aprepitant—Abdominal pain—Prednisone—psoriatic arthritis	6.55e-05	0.000818	CcSEcCtD
Aprepitant—Diarrhoea—Dexamethasone—psoriatic arthritis	6.51e-05	0.000813	CcSEcCtD
Aprepitant—Diarrhoea—Betamethasone—psoriatic arthritis	6.51e-05	0.000813	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—psoriatic arthritis	6.47e-05	0.000808	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	6.3e-05	0.000788	CcSEcCtD
Aprepitant—Dizziness—Dexamethasone—psoriatic arthritis	6.29e-05	0.000786	CcSEcCtD
Aprepitant—Dizziness—Betamethasone—psoriatic arthritis	6.29e-05	0.000786	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—psoriatic arthritis	6.26e-05	0.000782	CcSEcCtD
Aprepitant—Nausea—Triamcinolone—psoriatic arthritis	6.22e-05	0.000778	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—psoriatic arthritis	6.21e-05	0.000777	CcSEcCtD
Aprepitant—Nausea—Methylprednisolone—psoriatic arthritis	6.21e-05	0.000776	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—psoriatic arthritis	6.17e-05	0.000771	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—psoriatic arthritis	6.15e-05	0.000769	CcSEcCtD
Aprepitant—Hypersensitivity—Prednisone—psoriatic arthritis	6.1e-05	0.000763	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—psoriatic arthritis	6.09e-05	0.000761	CcSEcCtD
Aprepitant—Vomiting—Dexamethasone—psoriatic arthritis	6.05e-05	0.000756	CcSEcCtD
Aprepitant—Vomiting—Betamethasone—psoriatic arthritis	6.05e-05	0.000756	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—psoriatic arthritis	6.02e-05	0.000752	CcSEcCtD
Aprepitant—Rash—Dexamethasone—psoriatic arthritis	6e-05	0.000749	CcSEcCtD
Aprepitant—Rash—Betamethasone—psoriatic arthritis	6e-05	0.000749	CcSEcCtD
Aprepitant—Dermatitis—Dexamethasone—psoriatic arthritis	5.99e-05	0.000749	CcSEcCtD
Aprepitant—Dermatitis—Betamethasone—psoriatic arthritis	5.99e-05	0.000749	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	5.97e-05	0.000747	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—psoriatic arthritis	5.97e-05	0.000746	CcSEcCtD
Aprepitant—Headache—Dexamethasone—psoriatic arthritis	5.96e-05	0.000744	CcSEcCtD
Aprepitant—Headache—Betamethasone—psoriatic arthritis	5.96e-05	0.000744	CcSEcCtD
Aprepitant—Asthenia—Prednisone—psoriatic arthritis	5.94e-05	0.000743	CcSEcCtD
Aprepitant—Pain—Methotrexate—psoriatic arthritis	5.92e-05	0.00074	CcSEcCtD
Aprepitant—Pruritus—Prednisone—psoriatic arthritis	5.86e-05	0.000732	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—psoriatic arthritis	5.7e-05	0.000713	CcSEcCtD
Aprepitant—Diarrhoea—Prednisone—psoriatic arthritis	5.67e-05	0.000708	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—psoriatic arthritis	5.66e-05	0.000707	CcSEcCtD
Aprepitant—Nausea—Betamethasone—psoriatic arthritis	5.65e-05	0.000706	CcSEcCtD
Aprepitant—Nausea—Dexamethasone—psoriatic arthritis	5.65e-05	0.000706	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—psoriatic arthritis	5.5e-05	0.000687	CcSEcCtD
Aprepitant—Dizziness—Prednisone—psoriatic arthritis	5.48e-05	0.000684	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—psoriatic arthritis	5.47e-05	0.000684	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—psoriatic arthritis	5.47e-05	0.000684	CcSEcCtD
Aprepitant—Vomiting—Prednisone—psoriatic arthritis	5.26e-05	0.000658	CcSEcCtD
Aprepitant—Rash—Prednisone—psoriatic arthritis	5.22e-05	0.000653	CcSEcCtD
Aprepitant—Dermatitis—Prednisone—psoriatic arthritis	5.22e-05	0.000652	CcSEcCtD
Aprepitant—Headache—Prednisone—psoriatic arthritis	5.19e-05	0.000648	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—psoriatic arthritis	5.1e-05	0.000637	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—psoriatic arthritis	4.97e-05	0.000621	CcSEcCtD
Aprepitant—Nausea—Prednisone—psoriatic arthritis	4.92e-05	0.000615	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—psoriatic arthritis	4.9e-05	0.000612	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—psoriatic arthritis	4.73e-05	0.000592	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—psoriatic arthritis	4.58e-05	0.000572	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—psoriatic arthritis	4.4e-05	0.00055	CcSEcCtD
Aprepitant—Rash—Methotrexate—psoriatic arthritis	4.36e-05	0.000545	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—psoriatic arthritis	4.36e-05	0.000545	CcSEcCtD
Aprepitant—Headache—Methotrexate—psoriatic arthritis	4.34e-05	0.000542	CcSEcCtD
Aprepitant—Nausea—Methotrexate—psoriatic arthritis	4.11e-05	0.000514	CcSEcCtD
